11/19
11:41 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
11/19
11:41 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.
11/18
01:35 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
11/12
07:31 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating.
11/12
07:31 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was downgraded by analysts at Wolfe Research from a "peer perform" rating to an "underperform" rating.
11/12
05:19 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/12
05:19 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/4
08:19 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
11/1
02:13 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/1
02:13 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/1
12:38 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
11/1
12:38 pm
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $300.00 price target on the stock.
11/1
12:29 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/1
12:29 pm
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/1
10:21 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/1
10:21 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/1
09:46 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/1
09:46 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/1
08:27 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
11/1
08:15 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $320.00 price target on the stock.
Medium
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $320.00 price target on the stock.
11/1
08:15 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $300.00 price target on the stock.
Medium
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $300.00 price target on the stock.
11/1
08:14 am
alny
Rating for ALNY
Medium
Report
Rating for ALNY
11/1
06:05 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
11/1
06:05 am
alny
Rating for ALNY
Low
Report
Rating for ALNY
10/18
08:33 am
alny
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.